Skip to main content
Clinical Trials/NCT02372500
NCT02372500
Unknown
Not Applicable

Randomised Controlled Trial of Chewing Gum to Reduce Post Operative Ileus in Elective Colorectal Surgery

Countess of Chester NHS Foundation Trust1 site in 1 country130 target enrollmentMarch 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Colorectal Cancer
Sponsor
Countess of Chester NHS Foundation Trust
Enrollment
130
Locations
1
Primary Endpoint
Bowel function (as assessed by questionnaire)
Last Updated
11 years ago

Overview

Brief Summary

It is unknown whether post operative chewing gum will reduce post operative ileus. This study is a randomised controlled trial that will determine whether chewing gum three times a day following surgery will reduce post operative ileus. Time to passage of flatus will be used to determine that incidence of ileus.

Detailed Description

Patients will be randomised to one of two arms, the experimental arm will be chewing gum and the control arm will be normal post operative care. The primary endpoint is time to passage of flatus (defined as end of operation to first passage of flatus, in minutes). The trial will be unblinded to patients and observers and has been powered to demonstrate a 15% reduction in passage to flatus (130 patients required)

Registry
clinicaltrials.gov
Start Date
March 2015
End Date
October 2016
Last Updated
11 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Countess of Chester NHS Foundation Trust
Responsible Party
Principal Investigator
Principal Investigator

Dale Vimalachandran

Consultant Colorectal Surgeon

Countess of Chester NHS Foundation Trust

Eligibility Criteria

Inclusion Criteria

  • Undergoing elective colorectal surgery (open and laparoscopic), able to given informed consent

Exclusion Criteria

  • Emergency colorectal surgery, unable to consent

Outcomes

Primary Outcomes

Bowel function (as assessed by questionnaire)

Time Frame: Minutes (end of surgery to first passage of flatus, measured up to 4 weeks)

Time to passage of flatus

Secondary Outcomes

  • Diet (as assessed by questionnaire)(Minutes (end of surgery to first solid food, assessed by patient questionnaire up to 4 weeks from randomisation))
  • Length of stay(Days (till successful discharge from secondary care to home or respite care measured up to first 31 days))
  • Morbidity(Days (recorded up to 30 days and defined by Clavien-Dindo scale))
  • Post op nausea and vomiting score (as recorded by visual analogue scale)(Recorded daily for first 5 days)

Study Sites (1)

Loading locations...

Similar Trials